Biotechnology
20n Bio is a VC-backed start-up dedicated to the computational design of novel protein therapeutics. Their mission is is addressing unmet medical needs by leveraging artificial intelligence to generate protein drugs in silico with desired biophysical, functional, and pharmacological properties.